Infectious Optimism following the 10th International Oncolytic Virus Meeting

Matthew J. Atherton; Laura Evgin; Brian A. Keller; Mira M. Shenouda; Kyle B. Stephenson; Richard G. Vile; John C. Bell; David H. Evans; Brian D. Lichty

doi:10.1016/j.omto.2017.08.004

Infectious Optimism following the 10^th International Oncolytic Virus Meeting

Matthew J. Atherton, Laura Evgin, Brian A. Keller, Mira M. Shenouda, Kyle B. Stephenson, Richard G. Vile, John C. Bell, David H. Evans, Brian D. Lichty

Molecular Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The 10^th International Conference on Replicating Oncolytic Virus Therapeutics was held in Vancouver, Canada from October 1–4, 2016. The agenda for the meeting comprised lectures from several streams within the field of oncolytic viral therapeutics. Exploring the strengthening relationship among oncolytic viruses, cancer immunology, and immunotherapy; gaining an understanding for effective therapeutic delivery routes; and learning of exciting results from translational studies all featured prominently among areas discussed. As the field matures, commercialization and patient-centered research have become important avenues for growth; however, an abundance of high quality laboratory-based science continues to be performed in order to optimize future therapeutic approaches. Here, we summarize the latest innovations presented at this meeting.

Original language	English (US)
Pages (from-to)	12-16
Number of pages	5
Journal	Molecular Therapy Oncolytics
Volume	7
DOIs	https://doi.org/10.1016/j.omto.2017.08.004
State	Published - Dec 15 2017

Keywords

cancer immunotherapy
clinical trials
oncolytic virus

ASJC Scopus subject areas

Molecular Medicine
Oncology
Cancer Research
Pharmacology (medical)

Access to Document

10.1016/j.omto.2017.08.004

Cite this

@article{f192805862374821917be219796f92b4,

title = "Infectious Optimism following the 10th International Oncolytic Virus Meeting",

abstract = "The 10th International Conference on Replicating Oncolytic Virus Therapeutics was held in Vancouver, Canada from October 1–4, 2016. The agenda for the meeting comprised lectures from several streams within the field of oncolytic viral therapeutics. Exploring the strengthening relationship among oncolytic viruses, cancer immunology, and immunotherapy; gaining an understanding for effective therapeutic delivery routes; and learning of exciting results from translational studies all featured prominently among areas discussed. As the field matures, commercialization and patient-centered research have become important avenues for growth; however, an abundance of high quality laboratory-based science continues to be performed in order to optimize future therapeutic approaches. Here, we summarize the latest innovations presented at this meeting.",

keywords = "cancer immunotherapy, clinical trials, oncolytic virus",

author = "Atherton, {Matthew J.} and Laura Evgin and Keller, {Brian A.} and Shenouda, {Mira M.} and Stephenson, {Kyle B.} and Vile, {Richard G.} and Bell, {John C.} and Evans, {David H.} and Lichty, {Brian D.}",

note = "Publisher Copyright: {\textcopyright} 2017",

year = "2017",

month = dec,

day = "15",

doi = "10.1016/j.omto.2017.08.004",

language = "English (US)",

volume = "7",

pages = "12--16",

journal = "Molecular Therapy Oncolytics",

issn = "2372-7705",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Infectious Optimism following the 10th International Oncolytic Virus Meeting

AU - Atherton, Matthew J.

AU - Evgin, Laura

AU - Keller, Brian A.

AU - Shenouda, Mira M.

AU - Stephenson, Kyle B.

AU - Vile, Richard G.

AU - Bell, John C.

AU - Evans, David H.

AU - Lichty, Brian D.

PY - 2017/12/15

Y1 - 2017/12/15

N2 - The 10th International Conference on Replicating Oncolytic Virus Therapeutics was held in Vancouver, Canada from October 1–4, 2016. The agenda for the meeting comprised lectures from several streams within the field of oncolytic viral therapeutics. Exploring the strengthening relationship among oncolytic viruses, cancer immunology, and immunotherapy; gaining an understanding for effective therapeutic delivery routes; and learning of exciting results from translational studies all featured prominently among areas discussed. As the field matures, commercialization and patient-centered research have become important avenues for growth; however, an abundance of high quality laboratory-based science continues to be performed in order to optimize future therapeutic approaches. Here, we summarize the latest innovations presented at this meeting.

AB - The 10th International Conference on Replicating Oncolytic Virus Therapeutics was held in Vancouver, Canada from October 1–4, 2016. The agenda for the meeting comprised lectures from several streams within the field of oncolytic viral therapeutics. Exploring the strengthening relationship among oncolytic viruses, cancer immunology, and immunotherapy; gaining an understanding for effective therapeutic delivery routes; and learning of exciting results from translational studies all featured prominently among areas discussed. As the field matures, commercialization and patient-centered research have become important avenues for growth; however, an abundance of high quality laboratory-based science continues to be performed in order to optimize future therapeutic approaches. Here, we summarize the latest innovations presented at this meeting.

KW - cancer immunotherapy

KW - clinical trials

KW - oncolytic virus

UR - http://www.scopus.com/inward/record.url?scp=85041138103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041138103&partnerID=8YFLogxK

U2 - 10.1016/j.omto.2017.08.004

DO - 10.1016/j.omto.2017.08.004

M3 - Article

AN - SCOPUS:85041138103

SN - 2372-7705

VL - 7

SP - 12

EP - 16

JO - Molecular Therapy Oncolytics

JF - Molecular Therapy Oncolytics

ER -